Both in Pharmaceuticals
Parabilis Medicines vs Acadia Pharmaceuticals
Over the past year PBLS returned −23.6% and ACAD returned −27.0%; their daily moves had a correlation of 0.45.
PBLS −23.6% ACAD −27.0%Growth of $1, one year, split-adjusted
| Metric | PBLS | ACAD |
|---|---|---|
| Price | $28.17 | $20.32 |
| Market cap | $3.48B | $3.50B |
| Today | +6.26% | +0.74% |
| 1 month | −11.7% | +0.5% |
| 6 months | — | −8.5% |
| Year to date | — | −23.9% |
| 1 year | — | −11.6% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | 100.0% | 90.8% |
| Net margin | −45239.9% | 10.2% |
| P/E (TTM) | — | 9.2× |
| Price / sales | — | 3.1× |
| Net cash | $1.11B | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 45.9% |
| Short % of float | 9.1% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).